Medulloblastoma with myogenic and/or melanotic differentiation does not align immunohistochemically with the genetically defined molecular subgroups
Human Pathology Feb 18, 2018
Gupta K, et al. - An examination was conducted of the medulloblastoma (MB) with myogenic differentiation for the expression of 3 immunohistochemical markers (YAP1, GAB1, β-catenin) conventionally used in the molecular stratification of MB. These MB variants were discovered to be distinct and did not align immunohistochemically with the currently recognized genetic subgroups.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
